Case Study: Global Biopharma recovers $25M and strengthens financial controls with apexanalytix

Global Biopharma recovers $25M with apexanalytix

The customer, a global biopharmaceutical leader, faced significant challenges in managing its complex financial operations across multiple global divisions, systems, and approval workflows. This environment made it difficult to trace unclaimed credits and purchase order errors across over $30 billion in spend. To address this, the company partnered with apexanalytix for its audit and recovery services.

apexanalytix implemented a comprehensive disbursement and supplier statement review, analyzing over one million invoices to identify duplicate payments and unprocessed credits. The solution pinpointed division-specific risk patterns and root causes of errors. This effort by apexanalytix recovered $25 million for the customer in 2024, bringing total recoveries under their long-term partnership to more than $245 million, while also providing actionable insights for process improvements.

Global Biopharma